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doi:10.1016/j.jfma.2011.08.002Background/Purpose: Streptococcus pneumoniae is the most common bacterial cause of
community-acquired pneumonia in children. This study was designed to determine whether
a newly designed urinary antigen test score correlated with severity of pneumococcal pneu-
monia in children.
Methods: We recruited 119 children hospitalized with pneumonia diagnosed by positive
urinary pneumococcal antigen test at the National Cheng Kung University Hospital from
2002 through 2007. The urinary antigen reactivity score was determined by the rate of the
reaction time and intensity of the pneumococcal antigeneantibody band. The children were
stratified into three groups according to total score: group I, 8; group II, 5e7; and group III,
2e4. Disease severity was based on clinical presentation and radiological and laboratory
findings.
Results: Patients in group I had significantly more respiratory distress (p Z 0.01), oxygen
desaturation (p Z 0.04), febrile days (p Z 0.03), pulmonary complications (p Z 0.01),
and bacteremia (p Z 0.01), greater requirement for intensive care (p Z 0.004), longer
hospital stays (p < 0.001), and lower white blood cell counts (p Z 0.01) than patients in
group II or III.
Conclusion: A new urinary pneumococcal antigen test score correlated well with the severity
of pneumococcal pneumonia in children. It might provide helpful diagnostic and prognostic
information.
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614 C.-F. Shen et al.Accurate identification of the invading pathogen in children
with community-acquired pneumonia (CAP) continues to
be challenging. Streptococcus pneumoniae is the most
common bacterial etiological agent. Unfortunately sputum
cultures are often unreliable,1 and blood cultures are
positive in only 16e36% of cases.2e5 Several non-culture
methods have been developed to identify better the
potential pathogens of CAP. These include serological tests
for Mycoplasma pneumoniae, immunochromatographic
tests for S. pneumoniae and Legionella pneumophila
antigens in urine, and promising molecular diagnostic
modalities, including the polymerase chain reaction.6
Currently, urine immunochromatographic tests remain the
most convenient non-invasive methods to diagnose pneu-
mococcal infections. The sensitivity of the urinary
BinaxNOW Streptococcus pneumoniae@ test ranges from
63% to 80.4%. The specificity ranges from 89.7 % to 98.8
%.7,8 Although the urinary pneumococcal antigen test might
show false-positive results in children with nasopharyngeal
carriage, this test still provides useful information. S.
pneumoniae is part of the normal flora in children.
However, pneumococcal colonization is the key to pneu-
mococcal disease, and a positive urinary pneumococcal
antigen test helps to tailor antimicrobial therapy, particu-
larly in patients who have been partially treated.
CAP can vary in severity from mild, self-limiting illness
to severe, complicated fatal disease. Prompt assessment of
disease severity is crucial for appropriate clinical decisions.
CAP severity scores have been devised for adults, but are
less well defined for children.8e10 The urinary antigen test
for S. pneumoniae was originally designed for diagnostic
purposes. More recently, researchers have developed a new
semi-quantitative urinary antigen test to correlate the
kinetics of the antigen titers with disease severity.11 It has
been proposed that the amount of pneumococcal antigen
present in the urine is related to the magnitude of the
bacterial load in the lungs.
The current study was designed to determine whether
a novel urinary antigen reactivity score, based on the time
for the test to become positive and the intensity of the
reactive band, might be correlated with severity of pneu-
mococcal pneumonia.
Patients and methods
Patients
The population consisted of 119 children with pneumococcal
pneumonia who were hospitalized at the National Cheng
Kung University Hospital between February 2002 and
February 2007, and had a positive pneumococcal urinary
antigen test. The diagnosis of pneumonia was defined as
acute respiratory symptoms, including fever, cough,
tachypnea and shortness of breath, with evidence of a new
infiltrate on chest radiographs. Pneumonia was classified
as segmental, single lobe, multiple lobes with unilateral or
bilateral involvement, and acute respiratory distress
syndrome, by radiological features. Details of demographics,
past history, clinical and laboratory findings, hospital course,
therapeutic regimens, and outcome were obtained from the
medical records. Details of the clinical findings recordedsoon after admission were retrieved. Respiratory distress
was defined as using the accessory muscles of breathing,
whereas desaturation was defined as oxygen saturation
<92%. The characteristics of pleural effusion were based on
Light’s criteria for empyema.12 Complicated pneumonia was
defined as the additional presence of pleural effusion,
empyema, pneumothorax, pneumatocele, lung abscess,
and/or atelectasis with or without bacteremia. Children
with mycoplasma pneumonia within the study period were
also recruited as a comparative group, except those with
concurrent pneumococcal infection. Infection with Myco-
plasma pneumoniae was determined by serological tests,
which was defined as an antibody titer higher than 1: 640, or
a four-fold elevation in the convalescent serum compared
with baseline, as detected in two tests.
Microbiological studies
All patients underwent complete etiological survey,
including blood culture, sputum smear, sputum culture,
viral isolation, and Mycoplasma antibody upon admission.
Blood cultures were performed in all patients upon admis-
sion before antibiotic therapy. Patients with S. pneumoniae
isolated from sputum and nasopharyngeal cultures were not
included in the study because of the high rate of naso-
pharyngeal colonization in children. Patients were also
excluded from the study if a bacterial pathogen other than
S. pneumoniae was isolated from the blood or pleural
effusion, or if they had a mixed infection.
Urinary antigen test
Fresh urine samples were collected on admission and kept
at e20C until tested. The Binax NOW S. pneumoniae
(Inverness Medical, Scarborough, Maine, USA) was per-
formed according the manufacturer’s instructions.13 Pneu-
mococcal antigen present in the urine sample bound to
the anti-S. pneumoniae-conjugated antibodies, and the
resultant antigeneantibody complexes were captured by
immobilized anti-S. pneumoniae antibodies, which formed
the sample line. Immobilized goat anti-rabbit IgG captured
excess visualizing conjugate and formed the control line. A
positive test consisted of the appearance of a pink to purple
color on the sample line within 15 minutes.
Defined antigen reactivity score
The time of appearance of a detectable band over the
sample site was determined at specific intervals for up to 15
minutes. The intensity of the reactive band was scored
according to the intensity of the color of the reactive band
at 15 minutes (Table 1). The antigen reactivity score con-
sisted of the sum of the scores of the time of appearance
and intensity of the reactive band. This ranged from 2 to 8.
Patients were divided into three groups according to their
total score: group I, 8; group II, 5e7; and group III, 2e4.
Statistical analysis
Continuous variables were analyzed by Student’s t test and
presented as the mean and standard deviation. Categorical
Table 1 Criteria for urinary pneumococcal antigen reac-
tivity score
Antigen reactivity score (total score range 2e8) Score
Time to positive reaction
Within 1 min 5
1e2 min 4
2e5 min 3
5e10 min 2
10e15 min 1
Reaction band intensity
Deeper than control 3
Equal to control 2
Lighter than control 1
Total score
Group I 8
Group II 5e7
Group III 2e4
Pneumococcus urinary antigen test score 615variables were analyzed by Pearson’s c2 test and presented
with proportions. A p value <0.05 was considered to be
statistically significant.
Results
The demographic and clinical characteristics on admission
of the 119 children with pneumococcal pneumonia,
according to their urinary pneumococcal reactivity score,
are shown in Table 2. The laboratory, radiological and
microbiological findings are presented in Table 3 and theTable 2 Baseline characteristics of study population according
Group I (n Z 40)
Age, yr (mean  SD) 4.8  3.5
Male/female 18/22
No. %
With underlying disease or condition 5 12.5
Prior antibiotic use* 9/21 42.9
Pneumococcal vaccination 2 5
Physical findings upon admission
Fever >39C 21 52.5
Respiratory distress 20y 50y
Desaturation 25yx 62.5
Hypotension 9 22.5
Conscious disturbance 3 7.5
Acidosis* 5/25 16.7
Renal function impairment* 4/21 16
Liver function impairment* 5/36 13.9
* Missing data within these groups.
y Group I versus group III, p < 0.05.
z Group II versus group III, p < 0.05.
x Group I versus group II, p < 0.05.
SD Z standard deviation.clinical outcomes in Table 4. The underlying conditions
were: asthma (n Z 3), recurrent respiratory infection
within 3 months (n Z 2), cerebral palsy (n Z 6), immuno-
compromise (n Z 1), and diabetes mellitus (n Z 1).
There were no significant differences among the groups
for age, sex, underlying disease, prior antibiotic use, and
receipt of pneumococcal vaccine. Patients in group I had
significantly more respiratory distress (p Z 0.01), oxygen
desaturation (p Z 0.04), febrile days (p Z 0.03), pulmo-
nary complications (pZ 0.01), and bacteremia (pZ 0.01),
greater requirement for intensive care (p < 0.001), longer
hospital stays (p < .001) and lower white blood cell counts
(p Z 0.01), than patients in group II or III. Pleural effusion
was significantly more frequent in groups I and II compared
with group III (p < 0.05).
All patients were empirically treated with parenteral
penicillin or a second- or third-generation cephalosporin.
The antimicrobial regimen was adjusted according to
susceptibility tests. Patients in groups I and II more
frequently received fibrinolytic therapy than those in group
III (p < 0.05). Five patients (3 in group I and 2 in group II)
required surgical intervention. One patient was treated
with computed-tomography-guided aspiration of a lung
abscess, and four required lobectomy.
Children in group I had a significantly higher rate of
pulmonary complications and disseminated intravascular
coagulation than those in group III (p < 0.05). Two patients
died. One fatal case, which occurred in group I, was
complicated by septic shock, hemolytic uremia syndrome
and multiple organ failure. The other fatal case, which
occurred in group III, was complicated by Candida albicans
fungemia.
Thirty-five patients with mycoplasma pneumonia were
studied. There were no differences in demographicto urinary pneumococcal antigen reactivity score
Pneumococcal pneumonia
Group II (n Z 44) Group III (n Z 35)
5.2  3.3 4.8  3.7
27/17 22/13
No. % No. %
3 6.8 2 5.8
8/18 44.5 8/18 44.5
2 4.5 0 0
20 45.4 22 62.9
19z 43.2z 6 17.1
yx 15 34.1 7 20
4 9.1 5 14.3
2 4.5 0 0
0/27 0 1/14 7.1
1/29 3.4 1/11 9.1
1/40 2.4 1/30 3.3
Table 3 Laboratory, radiological and microbiology findings of the study population according to the urinary pneumococcal
antigen reactivity score
Pneumococcal pneumonia
Group I (n Z 40) Group II (n Z 44) Group III (n Z 35)
Laboratory data
WBC count, cells/mm3 14128  11397* 15863  8990 20223  12372
Hemoglobin, g/dL 10.6  1.9 11.2  1.5 11.2  1.4
Platelet count, 103cells/mm3 304.2  189.7 293.2  117.8 331.7  168.6
Immature myeloid cells, % 5.1  7.5* 2.0  4.1 0.8  1.6
Band forms, % 39.9  20* 42.1  19.9y 30  19.2
Segment cells, % 30  22.3*z 40.6  21.0 45.5  19.2
CRP, mg/L 217.8  106.8 255.5  131.2 208.4  106.2
No. % No. % No. %
Radiological findings
Segmental 1 2.5 5 11.4 2 5.7
Single lobar 16* 40* 22 50 24 68.6
Multiple lobar 23 57.5 17 38.6 9 25.7
Pleural effusion 27* 67.5* 21y 47.7y 6 17.1
Microbiological findings
Positive blood culture 10* 25* 5 11.4 1 2.9
Positive pleural effusion culture 5/27 18.5 3/21 14.2 0/6 0
Overall positives 14*z 35*z 7 15.9 1 2.9
*Group I versus group III, p < 0.05.
yGroup II versus group III, p < 0.05.
zGroup I versus group II, p < 0.05.
WBC Z white blood cell; CRP Z C-reactive protein.
Table 4 Comparison of clinical outcome and management of the study population according to the urinary pneumococcal
antigen reactivity score
Pneumococcal pneumonia
Group I (n Z 40) Group II (n Z 44) Group III (n Z 35)
Hospitalization duration, days, mean  SD 14.3  6.3*z 10.8  5.7y 7.0  3.0
Days of fever, mean  SD 6.1  4.9*z 4.1  4.1y 2.4  2.6
No. % No. % No. %
Management
ICU stay 30*z 75*z 21 47.7 10 28.6
Oxygen requirement 26*z 65*z 15 34.1 5 14.3
Intubation 8z 20z 1 2.3 2 5.7
Fibrinolytic therapy 21* 38.2* 14y 31.8y 3 8.6
Surgical intervention 3 7.5 2 4.6 0 0
Complications
Pulmonary 12* 30* 5 11.4 1 2.9
ARDS 1 2.5 1 2.3 2 5.7
Shock 10 25 4 9.1 3 8.6
DIC 8* 20* 3 6.8 1 2.9
HUS 4z 10z 0 0 0 0
Upper gastrointestinal bleeding 1 2.5 1 2.3 0 0
Mortality 1 2.5 0 0 1 2.9
*Group I versus group III, p < 0.05.
yGroup II versus group III, p < 0.05.
zGroup I versus group II, p < 0.05.
SD Z standard deviation; ICU Z intensive care unit; ARDS Z acute respiratory distress syndrome; DIC Z disseminated intravascular
coagulation; HUS Z hemolytic uremic syndrome.
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Pneumococcus urinary antigen test score 617information between children with mycoplasma or pneu-
mococcal pneumonia. There were also no significant
differences in clinical presentation, laboratory findings,
and outcome when comparing group III with the myco-
plasma pneumonia patients. However, children in groups I
and II had higher incidence of respiratory distress
(p < 0.005), more pulmonary complications (p < 0.05),
longer hospital stay, and greater need for intensive care
(p < 0.05) compared with the mycoplasma pneumonia
patients.Discussion
It is often difficult to assess the potential severity of
pneumococcal pneumonia in children based on their initial
presentation. The British Thoracic Society Standards of
Care Committee recommends the use of clinical parame-
ters, including body temperature >38.5C, respiratory rate
>50 breaths/min, respiratory distress, cyanosis and signs of
dehydration, to estimate the severity of childhood CAP.8
The clinical parameters can be misleading, because clin-
ical deterioration might be rapid and unexpected in chil-
dren. There is a need for more specific, independent
prognostic indicators to assess disease severity. The newly
defined pneumococcal antigen reactivity score based on
the time to positive reaction and the reaction band inten-
sity appears to meet this need. The current findings
demonstrate a significant correlation between the test
score and disease severity. These observations are in
accordance with those of Tateda et al.11 In their study,
serial two-fold dilutions of urine were used for antigen
testing, and the final dilution that was positive for antigen
was recorded as the maximum dilution factor. They have
noted that severe cases of S. pneumoniae pneumonia have
higher values of maximum dilution factors than those with
non-severe disease. By analyzing kinetics of urine antigen
titer, they also have found that the maximum dilution
factors decrease gradually after the disease is under
control. However, the semi-quantitative analysis consumes
more than one urine test kit. In contrast to their study, the
defined antigen reactive score in the current study is more
convenient, because it requires only one test kit and is less
labor intensive.
Relatively low white blood cell (WBC) counts in children
with pneumococcal pneumonia have been reported as an
independent risk factor for protracted fever and extended
hospitalization.14 In the current study, we found that chil-
dren with the highest pneumococcal urinary antigen scores
had significantly lower WBC counts and a higher proportion
of immature cells. This appears to be a response to greater
antigenic loads and immune activation.15 Other explana-
tions for the lower WBC counts are peripheral leukocyte
redistribution and inflammatory cell recruitment during
acute infection.
The standard pneumococcal urinary antigen test is
confounded by high prevalence of nasopharyngeal colo-
nization with S. pneumoniae in young children. The
antigen load can also be augmented by recurrent pneu-
mococcal infection in young children. The prevalence of
nasopharyngeal colonization with S. pneumoniae is highest
(27.2%) in Taiwanese children aged 2e5 years.16 Children inthis age group are the most vulnerable population for both
nasopharyngeal carriage and invasive pneumococcal
disease.17 However, the mean age of our enrolled patients
was about 5 years. The nasopharyngeal carriage rate
decreases gradually according to age, and the influence of
pneumococcal colonization on the urinary antigen test is
diminished.18,19 Besides, we observed that some older
children in the current study had excellent correlation
between disease severity and defined urinary antigen
score.
The current study had several limitations. First, this was
a retrospective study that relied on the data available in
the medical records. Second, it was not possible to isolate
S. pneumoniae from blood or pleural effusions in all cases.
Third, there might have been some overlap between colo-
nization and infection. Colonization has been proven to
cause positive pneumococcal antigen in urine; therefore,
low scores might have been due simply to colonization
rather than true infection. Another interpretation of this
study is that high urinary antigen scores indicated true
pneumococcal infection, but low scores did not. However,
there is still a need for a prospective controlled trial to
evaluate the ability of the new urinary antigen score to
differentiate between colonization and infection.
In summary, the urinary pneumococcal antigen test is
a useful diagnostic tool for evaluation of patients with CAP.
The newly designed antigen reactivity scoring system might
provide a useful, independent predictor of disease severity,
the need for hospitalization and prognosis.
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